1. Pharmacokinetics and effects of glibenclamide in two formulations, HB 419 and HB 420, in type 2 diabetes;Arnqvist;Ann. Clin. Res.,1983
2. Pharmaceutical quality of glibenclamide products. A multinational postmarket comparative study;Blume;Drug Dev. Ind. Pharm.,1993
3. Zur biologischen Verfugbarkeit von Glibenclamide in Abhangigkeit von der Teilchengrosse;Borchert;Pharmazie,1976
4. The polymorphism of bumetanide, of glibornuride and of chlorpromazine picrate;Borka;Acta Pharm. Suec.,1977
5. Correlation between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide;Chalk;Eur. J. Clin. Pharmacol.,1986